Pharmaceutical companies are on an M&A spree that could break records this year as they look for novel drug and clinical-stage candidates to bolster the development pipeline.

Elon Musk may have recently given a big hint about what's on the horizon for SpaceX and Tesla.

Shares of Churchill Capital Corp XI are trading higher Monday morning following last week’s announcement of a definitive ...

Platform graduates from successful pilot with more than 1,500 accounts, 185,000 plays delivered, a 44% average clickthrough rate on artist profiles, and a 33% free-to-paid conversion rate ...

A Practical Guide to Profitable, Principled Growth,” is now available from Forbes Books. Bench, co-founder of BW Health Group, shares insights on building a nationally recognized firm from a small ...

Patrick Industries (NASDAQ: PATK) (“Patrick”) and LCI Industries (NYSE: LCII) (“LCI” or “Lippert”) today announced they have entered into a definitive agreement to combine in an all-stock merger, ...

Economic success is not inevitable. It requires policies that encourage entrepreneurship, investment, innovation, and ...

Emirates NBD PJSC is reportedly in talks to acquire HSBC Holdings Türkiye operations, Bloomberg News reported on Tuesday, ...

Transaction expected to result in OpenPayd becoming a Nasdaq-listed public company under the ticker symbol "OP". Combined company expected to have an implied pro forma equity value exceeding $1 billio ...

AllianceBernstein trades near its 52-week low, offering an implied forward cash yield approaching 10%. See why I rate AB ...